Browse by People

Collapse authors list.
Kristeleit, Rebecca ORCID: 0000-0003-3825-1326, Plummer, Ruth, Jones, Robert ORCID: 0000-0001-5608-001X, Carter, Louise, Blagden, Sarah ORCID: 0000-0001-8783-3491, Sarker, Debashis ORCID: 0000-0003-4814-8429, Arkenau, Tobias, Evans, Thomas R Jeffry, Danson, Sarah, Symeonides, Stefan N ORCID: 0000-0002-9892-9314 et al (show 4 more authors) , Veal, Gareth J, Klencke, Barbara J, Kowalski, Mark M and Banerji, Udai ORCID: 0000-0003-1503-3123 (2023) A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer. British journal of cancer, 129 (1). pp. 38-45.

Collapse authors list.
Banerjee, Susana ORCID: 0000-0002-8840-7934, Michalarea, Vasiliki ORCID: 0000-0002-3102-3534, Ang, Joo Ern ORCID: 0000-0003-2103-996X, Ingles Garces, Alvaro ORCID: 0000-0002-0073-4237, Biondo, Andrea ORCID: 0000-0003-0599-254X, Funingana, Ionut-Gabriel ORCID: 0000-0002-1197-2652, Little, Martin ORCID: 0000-0003-2592-1570, Ruddle, Ruth ORCID: 0000-0003-0025-8872, Raynaud, Florence ORCID: 0000-0003-0957-6279, Riisnaes, Ruth ORCID: 0000-0002-8924-302X et al (show 19 more authors) , Gurel, Bora ORCID: 0000-0002-5018-8078, Chua, Sue ORCID: 0000-0001-5369-8156, Tunariu, Nina ORCID: 0000-0001-6656-3699, Porter, Joanna C ORCID: 0000-0002-7307-169X, Prout, Toby ORCID: 0000-0002-6465-4578, Parmar, Mona ORCID: 0000-0001-7818-4100, Zachariou, Anna ORCID: 0000-0002-7867-8327, Turner, Alison ORCID: 0000-0003-2915-2756, Jenkins, Ben ORCID: 0000-0002-2517-3595, McIntosh, Stuart ORCID: 0000-0002-7379-4505, Ainscow, Ed ORCID: 0000-0002-3119-8422, Minchom, Anna ORCID: 0000-0002-9339-7101, Lopez, Juanita ORCID: 0000-0001-8321-4212, de Bono, Johann ORCID: 0000-0002-2034-595X, Jones, Robert ORCID: 0000-0001-5608-001X, Hall, Emma ORCID: 0000-0001-5999-5020, Cook, Natalie ORCID: 0000-0003-2606-1082, Basu, Bristi ORCID: 0000-0002-3562-2868 and Banerji, Udai ORCID: 0000-0003-1503-3123 (2022) A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 28 (21). pp. 4634-4641.

Collapse authors list.
Jones, Robert ORCID: 0000-0001-5608-001X, Plummer, Ruth ORCID: 0000-0003-0107-1444, Moreno, Victor ORCID: 0000-0001-6099-4236, Carter, Louise ORCID: 0000-0002-9854-2304, Roda, Desamparados ORCID: 0000-0003-2657-9623, Garralda, Elena ORCID: 0000-0002-4412-7842, Kristeleit, Rebecca ORCID: 0000-0003-3825-1326, Sarker, Debashis ORCID: 0000-0003-4814-8429, Arkenau, Tobias ORCID: 0000-0002-2015-1549, Roxburgh, Patricia ORCID: 0000-0001-9869-591X et al (show 6 more authors) , Walter, Harriet S ORCID: 0000-0003-2618-711X, Blagden, Sarah ORCID: 0000-0001-8783-3491, Anthoney, Alan ORCID: 0000-0001-5695-8312, Klencke, Barbara J ORCID: 0000-0002-9518-2526, Kowalski, Mark M ORCID: 0000-0001-9590-6259 and Banerji, Udai ORCID: 0000-0003-1503-3123 (2023) A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 29 (2). pp. 331-340.